Unpredictable Chikungunya Outbreaks: New Research Aims to Improve Forecasting and Vaccine Development
A new study published in Science Advances sheds light on the unpredictable nature of chikungunya outbreaks and offers a path toward more effective public health planning and vaccine development. The mosquito-borne virus, while rarely fatal, causes debilitating joint pain and fever, posing a significant threat to vulnerable populations like newborns and the elderly.
Understanding the Chikungunya Threat
Chikungunya virus is prevalent in tropical and subtropical regions across Asia, Africa, and South America. However, recent infections have been reported in Europe, including a confirmed case in Long Island, New York, in September, signaling a potential expansion of the virus’s reach. Symptoms manifest rapidly, beginning with acute fever and followed by severe joint pain that can persist for months.
Public health officials have issued travel notices for areas experiencing outbreaks, including Bangladesh, Cuba, Guangdong Province in China, Kenya, Madagascar, Somalia, and Sri Lanka. In Guangdong Province, authorities responded to a recent “unprecedented” outbreak with mandatory quarantines, widespread mosquito repellent spraying, and insecticide application in affected areas.
A New Dataset for Predictive Modeling
Researchers at the University of Notre Dame have analyzed data from over 80 chikungunya outbreaks – the largest comparative dataset of its kind – to better understand the factors driving outbreak severity. The study, led by postdoctoral researcher Alexander Meyer, aims to improve predictions of future outbreaks and inform the development of effective vaccines.
“Chikungunya outbreaks are unpredictable in both size and severity,” explained Alex Perkins, a professor of infectious disease epidemiology and co-author of the study. “You can have one outbreak that infects just a few people, and another in a similar setting that infects tens of thousands. That unpredictability is what makes public health planning – and vaccine development – so difficult.”
Beyond Climate: Local Factors Drive Severity
While climate change and warmer temperatures are often linked to increased mosquito activity and the spread of mosquito-borne illnesses, the research suggests climate isn’t the primary driver of outbreak severity.
“Climate factors like temperature and rainfall can tell us where outbreaks are possible, but this study shows that they don’t help very much in predicting how severe they will be,” Perkins stated. “Local conditions matter – things like housing quality, mosquito density and how communities respond. Some variation is simply due to chance. That randomness is part of the story, too.”
Challenges in Vaccine Availability
Currently, only two chikungunya vaccines have received regulatory approval, but they are not widely accessible in the regions where the virus is most common. This underscores the importance of improved predictive modeling to facilitate targeted vaccine trials and ensure effective distribution when vaccines become available.
Researchers emphasize that accurate predictions of potential outbreak locations are crucial for testing vaccine efficacy. By identifying areas at high risk before an outbreak occurs, vaccine makers can conduct trials and monitor the effectiveness of candidate vaccines.
The study demonstrates that a comprehensive analysis of past outbreaks can significantly enhance public health preparedness, protect vulnerable populations, and accelerate vaccine development efforts against this challenging viral threat.
Source: Meyer, A. D., et al. (2025) Predictability of infectious disease outbreak severity: Chikungunya as a case study. Science Advances. doi.org/10.1126/sciadv.adt5419.
